Implementation and evaluation of a complex intervention to improve information availability at the interface between inpatient and outpatient care in older patients with multimorbidity and polypharmacy (HYPERION-TransCare) - study protocol for a pilot and feasibility cluster-randomized controlled trial in general practice in Germany.
Continuity of care
Family practice
Information availability
Inpatient and outpatient care
Multimorbidity
Older patients
Participation
Pilot projects
Polypharmacy
Randomized controlled trial
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
14
04
2022
accepted:
03
08
2023
medline:
23
8
2023
pubmed:
23
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
Despite attempts to improve the cross-sectoral flow of information, difficulties remain in routine healthcare. The resulting negative impact on continuity of care is often associated with poor health outcomes, especially in older patients. Our intervention aims to increase information availability with respect to medications and health conditions at the interface between inpatient and outpatient care and to contribute towards improving the quality of care in older patients. This pilot study focuses on feasibility and implementability. The idea of the complex intervention has been developed in a previous study. This intervention will be tested in a prospective, multicenter, cluster-randomized (via web tool), controlled pilot trial with two parallel study arms (intervention and control group). The pilot study will be conducted in 20 general practices in Hesse and Saxony (Germany) and include 200 patients (≥ 65 years of age with multimorbidity and polypharmacy) recruited by the practices. Practice staff and patients will be blinded. We will use qualitative and quantitative methods to assess the feasibility and implementability of the intervention and the study design in a process evaluation covering topics ranging from expectations to experiences. In addition, the feasibility of proposed outcome parameters for the future definitive trial will be explored. The composite endpoint will include health-related patient outcomes (hospitalization, falls, and mortality using, e.g., the FIMA questionnaire), and we will assess information on medications (SIMS questionnaire), symptoms and side effects of the medication (pro-CTCAE questionnaire), and health literacy (HLQ questionnaire). Data will be collected at study begin (baseline) and after 6 months. Furthermore, the study will include surveys and interviews with patients, general practitioners, and healthcare assistants. The intervention was developed using a participatory approach involving stakeholders and patients. It aims to empower general practice teams as they provide patient-centered care and play a key role in the coordination and continuity of care. We aim to encourage patients to adopt an active role in their health care. Overall, we want to increase the availability of health-related information for patients and healthcare providers. The results of the pilot study will be used in the design and implementation of the future definitive trial. The study was registered in DRKS-German Clinical Trials Register: registration number DRKS00027649 (date: 19 January 2022). Date and version identifier 10.07.2023; Version 1.3.
Sections du résumé
BACKGROUND
BACKGROUND
Despite attempts to improve the cross-sectoral flow of information, difficulties remain in routine healthcare. The resulting negative impact on continuity of care is often associated with poor health outcomes, especially in older patients. Our intervention aims to increase information availability with respect to medications and health conditions at the interface between inpatient and outpatient care and to contribute towards improving the quality of care in older patients. This pilot study focuses on feasibility and implementability.
METHODS
METHODS
The idea of the complex intervention has been developed in a previous study. This intervention will be tested in a prospective, multicenter, cluster-randomized (via web tool), controlled pilot trial with two parallel study arms (intervention and control group). The pilot study will be conducted in 20 general practices in Hesse and Saxony (Germany) and include 200 patients (≥ 65 years of age with multimorbidity and polypharmacy) recruited by the practices. Practice staff and patients will be blinded. We will use qualitative and quantitative methods to assess the feasibility and implementability of the intervention and the study design in a process evaluation covering topics ranging from expectations to experiences. In addition, the feasibility of proposed outcome parameters for the future definitive trial will be explored. The composite endpoint will include health-related patient outcomes (hospitalization, falls, and mortality using, e.g., the FIMA questionnaire), and we will assess information on medications (SIMS questionnaire), symptoms and side effects of the medication (pro-CTCAE questionnaire), and health literacy (HLQ questionnaire). Data will be collected at study begin (baseline) and after 6 months. Furthermore, the study will include surveys and interviews with patients, general practitioners, and healthcare assistants.
DISCUSSION
CONCLUSIONS
The intervention was developed using a participatory approach involving stakeholders and patients. It aims to empower general practice teams as they provide patient-centered care and play a key role in the coordination and continuity of care. We aim to encourage patients to adopt an active role in their health care. Overall, we want to increase the availability of health-related information for patients and healthcare providers. The results of the pilot study will be used in the design and implementation of the future definitive trial.
TRIAL REGISTRATION
BACKGROUND
The study was registered in DRKS-German Clinical Trials Register: registration number DRKS00027649 (date: 19 January 2022). Date and version identifier 10.07.2023; Version 1.3.
Identifiants
pubmed: 37608345
doi: 10.1186/s40814-023-01375-2
pii: 10.1186/s40814-023-01375-2
pmc: PMC10463488
doi:
Types de publication
Journal Article
Langues
eng
Pagination
146Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GK1906A/01GK1906B
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Barmer. Arzneimittelreport 2020 | BARMER. Available from: https://www.barmer.de/blob/254084/b1fa6438da1c611b757a7b74b982f62a/data/dl-barmer-arzneimittelreport.pdf [cited 24 Sep 2021].
Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Bedarfsgerechte steuerung der gesundheitsversorgung. GuS. 2018;72(6):37–43.
doi: 10.5771/1611-5821-2018-6-37
Forstner J, Bossert J, Weis A, Litke N, Strassner C, Szecsenyi J, et al. The role of personalised professional relations across care sectors in achieving high continuity of care. BMC Fam Pract. 2021;22(1):72.
doi: 10.1186/s12875-021-01418-8
pubmed: 33849453
pmcid: 8045382
Lang C, Gottschall M, Sauer M, Köberlein-Neu J, Bergmann A, Voigt K. „Da kann man sich ja totklingeln, geht ja keiner ran“ – Schnittstellenprobleme zwischen stationärer, hausärztlicher und ambulant-fachspezialisierter Patientenversorgung aus Sicht Dresdner Hausärzte. Gesundheitswesen. 2019;81(10):822–30.
doi: 10.1055/a-0664-0470
pubmed: 30114720
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16 Available from: https://jamanetwork.com/journals/jama/fullarticle/196099 .
doi: 10.1001/jama.289.9.1107
pubmed: 12622580
Meid AD, Quinzler R, Groll A, Wild B, Saum K-U, Schöttker B, et al. Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life. Eur J Clin Pharmacol. 2016;72(7):877–85 Available from: https://pubmed.ncbi.nlm.nih.gov/27023462/ .
doi: 10.1007/s00228-016-2047-8
pubmed: 27023462
Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Saljé K, Mueller S, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20(6):626–34 Available from: https://pubmed.ncbi.nlm.nih.gov/21384463/ .
doi: 10.1002/pds.2118
pubmed: 21384463
Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen. Koordination und Integration - Gesundheitsversorgung in einer Gesellschaft des längeren Lebens. 1st ed. Baden-Baden: Nomos; 2010.
Mahler C, Jank S, Pruszydlo MG, Hermann K, Gärtner H, Kaltschmidt J, et al. HeiCare® : ein Projekt zur Verbesserung der sektorenübergreifenden Arzneimittelkommunikation. Dtsch Med Wochenschr. 2011;136(44):2239–44.
doi: 10.1055/s-0031-1292036
pubmed: 22028288
National Guideline Centre. Multimorbidity: assessment, prioritisation and management of care for people with commonly occurring multimorbidity 2016. Available from: https://pubmed.ncbi.nlm.nih.gov/27683922/ .
Algahtani R, Merenda A. Multimorbidity and Critical care neurosurgery: minimizing major perioperative cardiopulmonary complications. Neurocrit Care. 2021;34(3):1047–61.
doi: 10.1007/s12028-020-01072-5
pubmed: 32794145
Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med. 2019;285(3):272–88.
doi: 10.1111/joim.12842
pubmed: 30357955
Wong JD, Bajcar JM, Wong GG, Alibhai SMH, Huh J-H, Cesta A, et al. Medication reconciliation at hospital discharge: evaluating discrepancies. Ann Pharmacother. 2008;42(10):1373–9 Available from: https://pubmed.ncbi.nlm.nih.gov/18780806/ .
doi: 10.1345/aph.1L190
pubmed: 18780806
Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011;306(8):840–7.
doi: 10.1001/jama.2011.1206
pubmed: 21862745
Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ. 2004;170(3):345–9.
pubmed: 14757670
pmcid: 331384
Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21 Available from: https://pubmed.ncbi.nlm.nih.gov/21401985/ .
doi: 10.3399/bjgp11X548929
pubmed: 21401985
Abholz H-H, Altiner A, Bahrs O, Baum E, Beyer M, Chenot J-F et al. DEGAM-Zukunftspositionen: Allgemeinmedizin - spezialisiert auf den ganzen Menschen [Positionen zur Zukunft der Allgemeinmedizin und der hausärztlichen Praxis]; 2012. Available from: https://www.degam.de/files/Inhalte/Degam-Inhalte/Ueber_uns/Positionspapiere/DEGAM_Zukunftspositionen.pdf [cited 4 Mar 2022].
Muth C, Harder S, Uhlmann L, Rochon J, Fullerton B, Güthlin C, et al. Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot). BMJ Open. 2016;6(7):e011613 https://bmjopen.bmj.com/content/6/7/e011613 .
doi: 10.1136/bmjopen-2016-011613
pubmed: 27456328
pmcid: 4964238
Muth C, Uhlmann L, Haefeli WE, Rochon J, van den Akker M, Perera R, et al. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial. BMJ Open. 2018;8(2):e017740.
doi: 10.1136/bmjopen-2017-017740
pubmed: 29478012
pmcid: 5855483
von Buedingen F, Hammer MS, Meid AD, Müller WE, Gerlach FM, Muth C. Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice. BMC Fam Pract. 2018;19(1):131.
doi: 10.1186/s12875-018-0825-3
El-Kurd N, Forstner J, Handlos B, Kaufmann-Kolle P, Pilz M, Rück R et al. Ergebnisbericht - Versorgungskontinuität sichern – Patientenorientiertes Einweisungs- und Entlassmanagement in Hausarztpraxen und Krankenhäusern. Available from: https://innovationsfonds.g-ba.de/downloads/beschluss-dokumente/88/2021-08-20_VESPEERA_Ergebnisbericht.pdf [cited 28 Oct 2021].
Mirk A, Echt KV, Vandenberg AE, Kemp L, Johnson TM, Perkins MM. Polypharmacy review of vulnerable elders: can we improve outcomes? Fed Pract. 2016;33(3):39–41.
pubmed: 27536053
pmcid: 4985243
Hu J, Wang Y, Li X. Continuity of care in chronic diseases: a concept analysis by literature review. J Korean Acad Nurs. 2020;50(4):513–22 Available from: https://pubmed.ncbi.nlm.nih.gov/32895338/ .
doi: 10.4040/jkan.20079
pubmed: 32895338
Schaeffer D, Berens E-M, Gille S, Griese L, Klinger J, Sombre S de et al. Gesundheitskompetenz der Bevölkerung in Deutschland vor und während der Corona Pandemie: Ergebnisse des HLS-GER 2; 2021.
Mangold A. Ambulante ärztliche Versorgung im Spannungsfeld zwischen verpflichtendem Primärarztmodell und freier Arztwahl. In: Market Access im Gesundheitswesen. Wiesbaden: Springer Gabler; 2020. p. 79–96 Available from: https://link.springer.com/chapter/10.1007/978-3-658-25141-3_5 .
doi: 10.1007/978-3-658-25141-3_5
Bratan T, Schneider D, Heyen NB, Pullmann L, Friedewald M, Kuhlmann D et al. E-Health in Deutschland: Entwicklungsperspektiven und internationaler Vergleich. Berlin: Expertenkommission Forschung und Innovation (EFI); 2022. Studien zum deutschen Innovationssystem 12–2022. Available from: http://hdl.handle.net/10419/251366 .
Treinat L. E-Health als Brücke zwischen den Leistungserbringern. In: E-Health-Ökonomie. Wiesbaden: Springer Gabler; 2017. p. 297–304 Available from: https://link.springer.com/chapter/10.1007/978-3-658-10788-8_16 .
doi: 10.1007/978-3-658-10788-8_16
Brueckle M-S, Dinh TS, Klein A-A, Rietschel L, Petermann J, Brosse F, et al. Development of an intervention to improve informational continuity of care in older patients with polypharmacy at the interface between general practice and hospital care: protocol for a participatory qualitative study in Germany. BMJ open. 2022;12(4):e058016. Available from: https://pubmed.ncbi.nlm.nih.gov/35387829/ .
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1 Available from: https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/1471-2288-10-1 .
doi: 10.1186/1471-2288-10-1
pubmed: 20053272
pmcid: 2824145
Leitliniengruppe Hessen. S3-Hausärztliche Leitlinie “Multimedikation”: Kurzversion; 2021. Available from: https://www.awmf.org/uploads/tx_szleitlinien/053-043k_S3_Multimedikation_2021-07.pdf [cited 2 Feb 2022].
Scherer M, Wagner H-O, Lühmann D, Muche-Borowski C, Schäfer I, Dubben H-H et al. Multimorbidität: Kurzversion. Available from: https://www.awmf.org/uploads/tx_szleitlinien/053-047k_S3_Multimorbiditaet_2017-11.pdf [cited 2 Feb 2022].
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
doi: 10.1136/bmj.e7586
pubmed: 23303884
pmcid: 3541470
Thabane L, Lancaster G. A guide to the reporting of protocols of pilot and feasibility trials. Pilot Feasibil Stud. 2019;5(1):37 Available from: https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-019-0423-8 .
doi: 10.1186/s40814-019-0423-8
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239 Available from: https://www.bmj.com/content/355/bmj.i5239 .
doi: 10.1136/bmj.i5239
pubmed: 27777223
pmcid: 5076380
Gehrke-Beck S. Hausarzt 15/21: Die DEGAM informiert. Der Hausarzt 2021(15):66. Available from: https://www.hausarzt.digital/medizin/forschung/forschungspraxennetz-allgemeinmedizin-dresden-frankfurt-am-main-saxoforn-98516.html [cited 2 Feb 2022].
Johann Wolfgang Goethe-Universität Frankfurt am Main. SaxoForN: Forschungspraxennetz Allgemeinmedizin Dresden/Frankfurt am Main. Available from: https://saxoforn.net/ [cited 18 Feb 2022].
Pirotta M, Temple-Smith M. Practice-based research networks. Aust Fam Phys. 2017;46(10):793–5 Available from: https://pubmed.ncbi.nlm.nih.gov/29036782/ .
Jacobs B. Zufällige Zuteilung von Versuchspersonen (Vpn) zu den experimentellen Gruppen: Universität des Saarlandes; 2012. Available from: http://bildungswissenschaften.uni-saarland.de/personal/jacobs/seminar/vpl_1/prinzipien/myrandomizer.htm [cited 11 Jul 2023].
Aktionsbündnis Patientensicherheit e.V. Patienteninformation: Arbeitsgruppe “Informieren - Beraten - Entscheiden” - Redaktionsteam “Sichere Arztpraxis”. Sicher in der Arztpraxis: Empfehlungen für Patientinnen, Patienten und ihre Angehörigen. Berlin; 2015.
Bundesministerium für Gesundheit, Referat Öffentlichkeitsarbeit. Tipps für eine sichere Arzneimitteltherapie. 2. Auflage. Berlin; 2015.
Dubben H-H, Lühmann D, Wagner H-O, Scherer M. DEGAM Patienteninformation: Menschen mit mehreren Krankheiten; 2017. Available from: https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S3-Leitlinien/053-047_Multimorbiditaet/053-047PI_Multimorbiditaet_13-11-2017.pdf .
Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:15 Available from: https://pubmed.ncbi.nlm.nih.gov/23311722/ .
doi: 10.1186/1745-6215-14-15
pubmed: 23311722
pmcid: 3600672
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50 Available from: https://pubmed.ncbi.nlm.nih.gov/19664226/ .
doi: 10.1186/1748-5908-4-50
pubmed: 19664226
pmcid: 2736161
Mahler C, Jank S, Hermann K, Horne R, Ludt S, Haefeli WE, et al. Psychometric properties of a German version of the “Satisfaction with Information about Medicines Scale” (SIMS-D). Value Health. 2009;12(8):1176–9.
doi: 10.1111/j.1524-4733.2009.00575.x
pubmed: 19659705
Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, et al. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2015;19(1):66–74 Available from: https://pubmed.ncbi.nlm.nih.gov/25190633/ .
doi: 10.1016/j.ejon.2014.07.007
pubmed: 25190633
Hagelstein V, Ortland I, Wilmer A, Mitchell SA, Jaehde U. Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™). Ann Oncol. 2016;27(12):2294–9 Available from: https://pubmed.ncbi.nlm.nih.gov/27681863/ .
doi: 10.1093/annonc/mdw422
pubmed: 27681863
pmcid: 6267864
Nolte S, Osborne RH, Dwinger S, Elsworth GR, Conrad ML, Rose M, et al. German translation, cultural adaptation, and validation of the Health Literacy Questionnaire (HLQ). PLoS One. 2017;12(2):e0172340.
doi: 10.1371/journal.pone.0172340
pubmed: 28234987
pmcid: 5325258
Seidl H, Bowles D, Bock J-O, Brettschneider C, Greiner W, König H-H, et al. FIMA–Fragebogen zur erhebung von gesundheitsleistungen im Alter: entwicklung und pilotstudie. Gesundheitswesen. 2015;77(1):46–52 Available from: https://pubmed.ncbi.nlm.nih.gov/24806594/ .
pubmed: 24806594
Seidl H, Hein L, Scholz S, Bowles D, Greiner W, Brettschneider C, et al. Validierung des FIMA-fragebogens zur inanspruchnahme von versorgungsleistungen anhand von routinedaten der krankenversicherung: welchen einfluss hat der erinnerungszeitraum? Gesundheitswesen. 2021;83(1):66–74.
doi: 10.1055/a-1010-6315
pubmed: 31698476
Nationaler Messplan Rehabilitation. CIRS - Cumulative Illness Rating Scale: Skala zur kumulierten Bewertung von Erkrankungen. Available from: https://www.anq.ch/fileadmin/redaktion/deutsch/CIRS_V_201303_D.pdf [cited 17 Jan 2022].
World Health Organization WHO. Falls; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/falls [cited 27 Oct 2021].
FAIR Principles. Available from: https://www.go-fair.org/fair-principles/ [cited 3 Feb 2022].
Mayring P. Qualitative Inhaltsanalyse: Grundlagen und Techniken. 12th ed. Weinheim: Beltz; 2015. Beltz Pädagogik.